EGFR and non-small cell lung carcinoma: To our knowledge, this is the first study conducted in Morocco that investigates the non-invasive prediction of EGFR mutation status in NSCLC patients through the application of machine learning techniques combined with multimodal-imaging-derived biomarkers.